Cite Filings / ABEO / 0001104659-25-097130
Feed Companies Filings Check
Sign in
SCHEDULE 13G

Statement of Beneficial Ownership

ABEONA THERAPEUTICS INC. · Filed 2025-10-06 · Acc 0001104659-25-097130

Documents 1

  • SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

  • 2025-10-30 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-10-06 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2025-10-06 SCHEDULE 13G Statement of Beneficial Ownership
  • 2025-10-01 4 SVP, Chief Legal Officer sold 9,366 shares at $5.39 ($50,516)
  • 2025-10-01 4 Chief Executive Officer sold 44,274 shares at an average $5.31 ($234,884)
  • 2025-10-01 4 Chief Financial Officer sold 9,035 shares at $5.39 ($48,730)
  • 2025-09-30 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · TPG GP A, LLC 7.0%
  2. 2026-11-16 SCHEDULE 13G · Rubric Capital Management LP 5.84%
  3. 2026-11-13 SCHEDULE 13G/A · Funicular Funds, LP 7.5%
Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…